midazolam and vx680

midazolam has been researched along with vx680 in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Abécassis, PY; Angouillant-Boniface, O; Bertrand, T; Bjergarde, K; Carry, JC; Clerc, F; Combeau, C; Crocq-Stuerga, V; Delarbre, L; Delorme, C; Doerflinger, G; Filoche-Rommé, B; Gasse, F; Gontier, S; Guizani, H; Krick, A; Lachaud, S; Le Moigne, R; Lebel, R; Ma, N; Maignan, S; Mauger, J; Minoux, H; Monget, S; Monteiro, ML; Murer, M; Nair, A; Nicolas, JP; Parmantier, E; Perron, S; Pouzieux, S; Prévost, C; Schio, L1

Other Studies

1 other study(ies) available for midazolam and vx680

ArticleYear
SAR156497, an exquisitely selective inhibitor of aurora kinases.
    Journal of medicinal chemistry, 2015, Jan-08, Volume: 58, Issue:1

    Topics: Animals; Antineoplastic Agents; Aurora Kinase A; Aurora Kinase B; Aurora Kinase C; Aurora Kinases; Benzimidazoles; Female; HCT116 Cells; Humans; Mice, SCID; Models, Chemical; Models, Molecular; Molecular Structure; Neoplasms; Protein Binding; Protein Kinase Inhibitors; Protein Structure, Tertiary; Quinolones; Sf9 Cells; Small Molecule Libraries; Xenograft Model Antitumor Assays

2015